Jiangsu Nanfang Medical Co., Ltd.

Shanghai Stock Exchange 603880.SS

Jiangsu Nanfang Medical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2023: 0.96

Jiangsu Nanfang Medical Co., Ltd. Debt to Equity Ratio is 0.96 for the year ending December 31, 2023, a 25.57% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
  • Jiangsu Nanfang Medical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 0.77, a 41.02% change year over year.
  • Jiangsu Nanfang Medical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 0.54, a 113.59% change year over year.
  • Jiangsu Nanfang Medical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 0.25, a 1.28% change year over year.
  • Jiangsu Nanfang Medical Co., Ltd. Debt to Equity Ratio for the year ending December 31, 2019 was 0.25, a -10.17% change year over year.
Key data
Date Debt to Equity Ratio Debt to Income Ratio Debt to Tangible Net Worth Ratio Dividend Coverage Ratio
Market news
Loading...
SV Wall Street
Shanghai Stock Exchange: 603880.SS

Jiangsu Nanfang Medical Co., Ltd.

CEO Mr. Ping Li
IPO Date Aug. 7, 2017
Location China
Headquarters 1 Guoxiang Road
Employees 858
Sector Health Care
Industries
Description

Jiangsu Nanfang Medical Co., Ltd. engages in the research and development, production, and sale of transdermal products, medical proof fabrics, adhesive tapes, bandages, sports protection products, first-aid kits, and care products in China and internationally. It offers medical adhesive tapes, medical wound dressings, capsicum plasters, physical therapy tapes, pain relief sleeves, rigid sports tapes, wound plaster dressings, medical eye pads, elastic stretch tapes, corn removal plasters, waterproof adhesive tapes, pain relief patches, kinesiology tapes, surgical tapes, zinc oxide adhesive plasters, and masks, as well as customized products. The company was founded in 1990 and is based in Changzhou, China.

Similar companies

603309.SS

Well Lead Medical Co., Ltd.

USD 1.62

1.11%

603233.SS

DaShenLin Pharmaceutical Group Co., Ltd.

USD 1.95

1.92%

603987.SS

Shanghai Kindly Enterprise Development Group Co.,LTD.

USD 1.01

1.16%

603301.SS

Zhende Medical Co., Ltd.

USD 3.02

1.95%

603882.SS

Guangzhou Kingmed Diagnostics Group Co., Ltd.

USD 3.37

-1.70%

StockViz Staff

January 31, 2025

Any question? Send us an email